This PR Newswire announcement highlights the launch of the first-ever Hashimoto’s Disease Awareness Day, initiated by the Clayman Thyroid Center and observed annually on March 12. This milestone event aims to raise awareness of Hashimoto’s thyroiditis, the most common autoimmune thyroid disorder, and to improve early diagnosis, patient education, and public understanding of this often-overlooked condition.
Hashimoto’s disease occurs when the body’s immune system attacks the thyroid gland, leading to inflammation and decreased hormone production, which may eventually result in hypothyroidism. Symptoms can include fatigue, depression, weight gain, cold intolerance, and brain fog—many of which are subtle and frequently misattributed to other causes. The announcement emphasizes how Hashimoto’s is frequently underdiagnosed or misdiagnosed, particularly in women.
The Clayman Thyroid Center’s Awareness Day is designed to spotlight the importance of thyroid health, promote proactive screening, and provide science-based education on Hashimoto’s and other autoimmune thyroid disorders. The campaign includes expert interviews, educational content, patient stories, and outreach initiatives to healthcare providers and the public.
The announcement also serves as a call to action for increased research, better diagnostic tools, and patient-centered care. The Clayman Thyroid Center encourages individuals experiencing persistent symptoms to speak with their healthcare providers about thyroid testing, particularly TSH, Free T3, Free T4, and thyroid antibodies.
With the creation of Hashimoto’s Disease Awareness Day, the Clayman Thyroid Center is leading the way in transforming how this chronic condition is recognized and managed. The goal is to empower patients with knowledge, reduce stigma, and promote earlier intervention—ultimately improving outcomes and quality of life for millions affected by this autoimmune disorder.
